Bulk Good Manufacturing Practice system to launch next year.

The MOHW drafted the revised working rules of the pharmaceutical affairs law to launch it from March 2, in which drugs would not be granted to manufacture if infringed other patent rights and the good manufacturing practice system (BGMP) apply even to the bulk pharmaceutical material production from Jan. next year.

The new provision stipulates in the Article 40 that the manufacturer shall se...